Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071896 · ClinicalTrials.gov registry record · NA
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors
A NA study of Mastectomy, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT07071896: Recruiting NA study of Mastectomy, sponsored by University of California, San Diego.
NCT07071896 is a NA study of Mastectomy that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 15 participants, below the 131-participant average among 8 other Mastectomy trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071896, a NA study of Mastectomy, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators cancer rehabilitation/recovery program, Strong Survivor, has been designed to be delivered digitally, and while there are many such programs currently available on the internet, especially in the time of COVID-19, the novel feature of this program is the delivery of semi-individualized instruction in real time within a small group setting. The program was designed with physician input and by exercise physiologists and a Doctor of Physical Therapy candidate, all with extensive training in both group and individualized exercise for geriatric and cancer survivor populations. Strong Survivor is 16-week iterative curricular program with three core components: aerobic fitness, balance and mobility, and muscular strength and power. Classes will be held twice per week. The first 4 classes will be deployed in a small class of up to 5 people (first 2 weeks), then one class per week with the small class and one class per week is with a larger class of up to 15 people (weeks 3 and 4). The program is then continued for 12 additional weeks in a larger class using principles and exercises specifically trained during the small group classes. All the exercises offered over the course of the intervention are appropriate for the target population and are standardized so all participants receive the same basic instruction, but level of difficulty is scaled to participant experience, capability, and musculoskeletal limitations. Participants will need to have a minimal adequate space and technology to accommodate this instructional method. Specifically, they will require an internet connected device with a camera that is at least 7 inches square. (tablet size or larger). Additionally, participants' will need to have adequate space to both set up a computer/camera and move around. The minimal acceptable space for this is 6+ feet with an unobstructed view (from a table for instance) of a 2 x 2 open space. All study participants will complete a clinic visit before they
Primary Outcome
The number of sessions each participant attended (out of the total number of sessions offered) will be recorded and used to evaluate engagement in the tele-video real time exercise program in a geriatric breast cancer patient population. A participant is considered to have completed the study if he or she has completed all phases of the study including responding to follow up queries regarding falls for up to 1 year following the final measurement visit. Acceptability is based on attendance.
Conditions Studied
Interventions
- OTHER 16 weeks remotely exercise program
Study Locations (2)
California
- UCSD - San Diego
- UCSD - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2026-12-23 |
| Phase | NA |
What NCT07071896 shows while recruiting
NCT07071896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 131-participant average among 8 other Mastectomy trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Mastectomy appearing as the primary indexed condition, and to 1 intervention - of which 16 weeks remotely exercise program is the first listed.
NCT07071896 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07071896 about?
NCT07071896 is a clinical study titled "A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors". The investigators cancer rehabilitation/recovery program, Strong Survivor, has been designed to be delivered digitally, and while there are many such programs currently available on the internet, especially in the time of COVID-19, the novel feature of this program is the delivery of semi-individual...
What is the current status of trial NCT07071896?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-01-10. Estimated completion is 2026-12-23.
What conditions does trial NCT07071896 study?
This clinical trial studies the following conditions: Mastectomy.
What interventions are being tested in trial NCT07071896?
The interventions under investigation include: 16 weeks remotely exercise program (OTHER).
Who is sponsoring clinical trial NCT07071896?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071896 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mastectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07071896's enrollment target sits among peer trials
15 8th of 8 higher than 1 of 8 other Mastectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mastectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study on Pain After Breast Reconstruction
RECRUITING · NA
-
A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy
RECRUITING · NA
-
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
RECRUITING · NA
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Assessment of the Interi Manifold in Implant-Based Breast Reconstruction
RECRUITING · NA
-
Interactive Design of Patient-Specific Molds for Tissue Shaping
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI